ENG and hereditary hemorrhagic telangiectasia: Finally, low expression of Endoglin is associated with improved clinical outcome in several cancers41,42, and cancer patients with concurrent hereditary hemorrhagic telangiectasia (HHT), a hereditary condition caused by deleterious ENG mutations show longer survival43.